I agree with you BC. I don't think Don really knew how many events to date occured on Sept 12 but had to provide an answer to the question. We all understand the basic math of when the trial should end based on the information that is out there, but I think something unexpected has shown up (good or bad) and things are getting stretched out on the time line. It could be a buy out or a failed outcome, otherwise  why aren't we at or over the magical 250 event end of trial number. First it was Q 1 and then H1. We know there are no safety issues or problems with the trial design. It is my opinion that they are timing the release of the primary out come with the anouncement of a buy out with Hepa Link although there are some that think they cant afford what we beleive would a reasonable price. Hope that is the case. JMHO.